Pall® Freeze & Go Solutions Protected by RoSS* Technology
Some combinations are so strong it's simply genius. But when you combine Pall's end-to-end support and class-leading Allegro™ biocontainers with RoSS technology - that's cryogenius.
Discover a new one-stop solution for the frozen storage and transport of your drug substance that’s safe, protected, supported and tailored to your process.
See a work of cryogenius!
You will learn:
- How Freeze & Go Solutions can minimize product loss between bulk filling and final filling production steps
- The cost and product quality benefits of controlled freezing in single-use biocontainers
- How comprehensive extractables and leachables and transport validation packages contribute to a one-stop solution
Speaker
Claire Jarmey-Swan
Global Product Manager, Pall Corporation
David Rigterink
Freeze/Transport & Thaw Platforms Specialist, Pall Corporation
Johannes Kirchmair
Co-founder and CEO, Single Use Support GmbH
Patrick Evrard
Senior Principal Engineer, Pall Corporation
Peter Black
R&D Engineer II, Pall Corporation
Book Your Virtual Freeze & Go Seminar Today!
Discover more by booking an in-depth seminar customized to your needs including a virtual facility tour. Join our experts and learn more how Pall Freeze & Go Solutions protect against leakages and product loss.
Biotech | Pall Corporation webinar series
This webinar was recorded by BioPharma Asia and first published on their website. https://biopharma-asia.com. It is made available here by kind permission of BioPharma Asia and the presenters.
Hailed as the “next frontier” in cell therapy and regenerative medicine, exosomes are a type of extracellular vesicle and play a key role in the regulation of the intercellular communication processes.
David Haylock of VivaZome will present on upstream production of angiogenic exosomes using the iCELLis® nano fixed bed bioreactor. This will be followed by a presentation by Roberto Ciboldi of Pall Corporation on a platform solution including cell culture, purification and sterile filtration of exosomes.
Participants will be able to:
- Compare the performance of the iCELLis Nano bioreactor to traditional flasks for exosome production from adherent cell culture
- Understand how an integrated end to end platform delivers highly purified and consistently-sized exosomes
- Discover an innovative cGMP scalable manufacturing platform for exosomes